Genotype Allele Country Type and size of the study Association OR / RR References
ERα- 397 T/C   Pvull TT USA pre-andpostmenopausal Only Cases / Case Control 257/140 Diagnosis in youngerwomen   Yaich et al.  [9]
  TT Shanghai, China Case / control 1069/1166 ↑ risk for breastcancer OR: 1.4 IC 95%: 1.1-1.8 p= 0.042 Cai et al. [10]
  TT Netherlands Case / control 380/422 ↑ risk for breastcancer RR: 1.5 IC 95%: 0.94-2.42 Onland-Moret et al. [11]
  TT China 25 a 55 years-old Case / control 259/278 ↑ risk of breast cancer in women with a positive family history OR: 3.04 IC 95%: 0.73-12.67 Shen et al. [12]
                TT Spain 26 to 86 years-old Case / control    444/704 ↑ risk of breast cancer in women with a positive family history OR: 3.81 IC 95%: 1.25- 11.6 Gonzalez-Mancha et al. [13]
  TT Netherlands 55 yearsor more Case / control 190/3513 ↑ risk of breast cancer in women after menopause OR: 1.4 IC 95%: 0.8-2.2 Ladd et al.2007 [14]
  TT USA peri-menopause  42 to 52 years-old longitudinal cohort      451 ↑ Increased mammographic density in white women 7,0%; p=0,01 Crandall et AL [15]
  TT Brazil After-menopause Only cases 308women Mammographicdensity> 50% TT=32,14% greaterthan CC=20,13% Souza et al. [16]
  TT/ TC Netherlandsand England After -menopause Population Cohort prospective case / control (795 withHT/781 with no HT) ↑ Increased mammographic density only in HT users 2.24% p<0.01 van Duijnhoven et al.[17]
  TC Netherlands Caso/controle380/422 ↑ risk for BC OR: 1.14 IC 95%: 1.00-1.32 Onland-Moret et al. [11]
  TC China 25 - 55 anos Case / control 259/278 ↑ risk for BC(with family history) OR: 2.46 IC 95%: 0.61-9.88 Shen et al. [12]
  CC Shanghai, China 22-64 years-old ProspectivePopulationCohort 1459 cases RE negative expression; worse prognosis for breast cancer OR: 3.30 IC 95%: 1.42-7.69 Boyapatti et al. [5]
  CC Netherlands and England After- menopause Population Cohort prospective case / control [795/781] Mammographic density without changes in user HT 0.90% p= 0.47 van Duijnhoven et al.[17]
Table 1: Association studies of the ERα-397 gene polymorphism PvuII C/T with BC and/or risk factors for disease.